Methods for modulating KLHL1 levels, methods for modulating current activity in T-type calcium channels, molecules therefor, and methods for identifying molecules therefor

Methods for improving cognitive function via modulation of quinone reductase 2

Method of Modulating Fibroblast Accumulation or Collagen Deposition

NUCLEIC ACID THAT INHIBITS EXPRESSION OF IRF5

METHODS AND COMPOSITIONS FOR PREVENTING ISCHEMIA REPERFUSION INJURY IN ORGANS

Retinoid-lipid drug carrier

COMPOUNDS, COMPOSITION, METHODS, TARGETS FOR CANCER THERAPY

Cell penetrating peptides for intracellular delivery of molecules

Polypeptides having peroxygenase activity

Polypeptides Having Peroxygenase Activity

Peptide containing conjugates for dual molecular delivery of oligonucleotides

Anti-PVRIG antibodies and methods of use

Carrier nanoparticles and related compositions, methods and systems

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

Technology for the Preparation of Microparticles

ANTAGONISTS OF SLC38A9 AND THEIR USE IN THERAPY

MELK Regulation for the Treatment of Breast Cancer

Cell-type specific aptamer-siRNA delivery system for HIV-1 therapy

RNAi-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma

Treatment of Collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene

Compositions and Methods for Selective Delivery of Oligonucleotide Molecules to Cell Types

Organic compositions to treat HSF1-related diseases

Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma

MiR-320e and colorectal cancer

Invertebrate microRNAs

Compositions and methods for inhibiting expression of CD274/PD-L1 gene

SUGAR CHAIN-RELATED GENE AND USE THEREOF

RNA interference in dermal and fibrotic indications

Skin and hair color-controlling factor

RNA-interference by single-stranded RNA molecules

MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1

Reprogramming of human wharton's jelly cells to produce hair cells

Esophageal cancer marker and use thereof

Metal-particle-based oral-administrating liver-specific nucleic acid delivery system and method of manufacturing the same

Eukaryotic cells and methods for recombinantly expressing a product of interest

SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions

COMPOSITIONS AND METHODS OF USING SAME FOR CONTROLLING PATHOGENICALLY INFECTED MOSQUITOES

METHODS FOR MODULATING IMMUNE RESPONSES DURING CHRONIC IMMUNE CONDITIONS BY TARGETING IL-27 INDUCED PATHWAYS

Compositions and methods for transport across the blood brain barrier

LOW DENSITY LIPOPROTEIN RECEPTOR-MEDIATED siRNA DELIVERY

Methods of treating autoimmune conditions in patients with genetic variations in DcR3 or in a DcR3 network gene

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders

METHODS FOR TREATMENT OF DISORDERS IN THE FRONT OF THE EYE UTILIZING NUCLEIC ACID MOLECULES

Composition for enhancing radiation sensitivity comprising PI4K isozyme inhibitor

Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT

COMPOSITIONS AND METHODS OF USING SAME FOR REDUCING RESISTANCE TO MOSQUITO LARVICIDES

RNA interference for the treatment of gain-of-function disorders

Method and composition for diagnosis or treatment of aggressive prostate cancer

Compositions comprising a mitofusin inhibitor for promoting cell reprogramming and a use thereof

Methods and Pharmaceutical Compositions for the Treatment of Diseases Mediated by the NRP-1/OBR Complex Signaling Pathway

Therapeutic drug for malignant tumors

P97-polynucleotide conjugates

MULTIBLOCK COPOLYMERS

Pharmaceutical combination comprising a CIP2A silencing agent for use in the treatment of a hyperproliferative disorder, preferably one with impaired P53 function

Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes

Targeting PARP1 for treatment of TSC and cancers

Genetic alterations on chromosome 16 and methods of use thereof for the diagnosis and treatment of type 1 diabetes

Recombinant RNA particles and methods of producing proteins

Polycomb-associated non-coding RNAs

SiRNA in tandem expression and uses thereof in treating chronic lymphocytic leukemia

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Compositions and methods to promote erythropoiesis

SARNA COMPOSITIONS AND METHODS OF USE

Methods for producing enteroendocrine cells that make and secrete insulin

Transposon Activation During Aging and Neuronal Decline

tRNA derived small RNAs (tsRNAs) involved in cell viability

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

Antibodies and processes for preparing the same

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

Bioactive conjugates for oligonucleotide delivery

Compositions and methods for modulating stem cells and uses thereof

Compositions and methods for treating hepatitis B

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

Methods for treating T-cell acute lymphoblastic leukemia

USE OF CASEIN KINASE I INHIBITORS FOR DEPLETING STEM CELLS

LIPID NANO PARTICLES COMPRISING CATIONIC LIPID FOR DRUG DELIVERY SYSTEM

NANOPARTICLES FOR TARGETED GENE THERAPY AND METHODS OF USE THEREOF

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

NEAT1 as a prognostic marker and therapeutic target for prostate cancer

Compositions and methods for virus control in mite and bees

Pharmaceutical composition comprising Nanog shRNA, and method of using Nanog shRNA to treat cancer

LncRNAs for therapy and diagnosis of angiogenesis

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES

MODULATING IMMUNE RESPONSES

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

Targeted therapy to restore radioactive iodine transport in thyroid cancer

Methods for treating and/or limiting development of diabetes

Compositions and methods for controlling pests

RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)

TRUNCATED TRK B AND TRK C ANTAGONISTS AND USES THEREOF

Treatment using truncated Trk B and Trk C antagonists

Methods for eliminating or reducing the expression of genes in filamentous fungal strains by transitive RNA interference

Plant-protecting RNAi compositions comprising plant-protecting double-stranded RNA adsorbed onto layered double hydroxide particles

RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

Transthyretin (TTR) iRNA compositions and methods of use thereof for treating or preventing TTR-associated diseases

Multivalent oligonucleotide assemblies

RNAi agents modified at the 4′-C position

Agents useful in treating facioscapulohumeral muscular dystrophy

Anti-PVRIG antibodies and methods of use

Use of inhibitors of leukotriene B4 receptor BLT2 for treating asthma

Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo

MultiLigand agent for drug delivery

RNA interference functions as an antiviral immunity in mammals

CaMKK-β as a target for treating cancer

RNA complexes that inhibit melanin production

Tools and Methods for Targeting Oligonucleotide Repeat RNA Toxicity

Nucleic acid molecules to control insect pests

Methods of Producing a Secreted Protein

Small molecule conjugates for intracellular delivery of biologically active compounds

Polycomb-associated non-coding RNAs

Methods of modulating WARS2

METHOD OF TREATING KELOIDS OR HYPERTROPHIC SCARS USING ANTISENSE COMPOUNDS TARGETING CONNECTIVE TISSUE GROWTH FACTOR (CTGF)

Targeting molecule and a use thereof

METHOD OF REGULATING GENE EXPRESSION

Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo

REDUCTION OF OFF-TARGET RNA INTERFERENCE TOXICITY

Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents

Combination therapy for the treatment of autoimmune diseases

Compositions and methods for nanoparticle lyophile forms

PRP8 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

SNAP25 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

Pharmaceutical composition and method for reducing scar formation

Composition for promoting chondrocyte differentiation or treating cartilage diseases, containing KLF10 expression inhibitor, and method for promoting cartilage differentiation by using same

Method of Treating Cancer by Inhibition of DNA Repair Proteins

ASYMMETRIC INTERFERING RNA COMPOSITIONS THAT SILENCE K-RAS AND METHODS OF USES THEREOF

Low molecular weight cationic lipids for oligonucleotide delivery

Methods of treating or preventing pruritis by blocking natriuretic polypeptide B

Induction of thyroid iodide-handling gene expression in human cancers

SGK1 INHIBITORS FOR TREATMENT OF PROSTATE CANCER

RNA interference in skin indications

Short interfering RNA (siRNA) analogues

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

Methods used to treat cancer

Inhibition of NEAT1 for treatment of solid tumors

BIOLOGICAL MATERIALS AND THERAPEUTIC USES THEREOF

DOWNREGULATION OF miR-7 FOR PROMOTION OF BETA CELL DIFFERENTIATION AND INSULIN PRODUCTION

COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

Trialkyl cationic lipids and methods of use thereof

Compositions and methods for treating diabetes

Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders

Microbubble complexes and methods of use

TREATMENT OF NEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES BY INHIBITION OF THE a2-Na/K ATPase/a-ADDUCIN COMPLEX

Multi-targeting short interfering RNAs

COMPOSITION FOR REDUCING CELLULAR SENESCENCE LEVEL INCLUDING ACTIVITY INHIBITOR INHIBITING DCUN1D3 ACTIVITY OR EXPRESSION INHIBITOR INHIBITING EXPRESSION OF DCUN1D3-ENCODING GENE AND USE THEREOF

SiRNA targeting PRK2, which is hepatitis C virus therapeutic agent

PROTEIN PHOSPHATASE INHIBITOR

Method for treatment of heart failure

HBV treatment

Inhibitors of thioredoxin-interacting protein (TXNIP) for therapy

Compositions and methods for reducing C/EBP homologous protein activity in myeloid-derived suppressor cells

TAILED MIRTRON EFFECTORS FOR RNAI-MEDIATED GENE SILENCING

SMALL RNA, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS FOR SPECIFICALLY UP-REGULATING GENE TRANSCRIPTIONAL ACTIVITY

Compositions and methods for modulating an immune response

Eukaryotic cells and methods for recombinantly expressing a product of interest

Compounds for targeting drug delivery and enhancing siRNA activity

Compounds for targeting drug delivery and enhancing siRNA activity

Methods and Compositions for Inhibiting Mitochondrial Trafficking

Methods for treating diet-induced obesity by decreasing or inhibiting P2Y2 purinergic receptor expression or activity

RNAi inhibition of alpha-ENaC expression

Polycomb-associated non-coding RNAS

iRNA agents with biocleavable tethers

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

Molecular re-engineering of excitation-inhibition balance in memory circuits

Oligonucleotide-ligand conjugates and process for their preparation

METHOD OF TREATING CANCER

Adeno-associated virus virions with variant capsid and methods of use thereof

Biocompatible flavonoid compounds for organelle and cell imaging

Adeno-associated virus virions with variant capsid and methods of use thereof

MIKTO-ARM BRANCHED POLYMERS

TYROSINE-PHOSPHORYLATED WBP2, A NOVEL CANCER TARGET AND BIOMARKER

METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES

COMPOSITIONS

Peptide/particle delivery systems

METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME

Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)

Polypeptides having peroxygenase activity

Parental RNAI suppression of kruppel gene to control hemipteran pests

RNAi targeting SEC61G

RNAi-Mediated Inhibition of Tumor Necrosis Factor Alpha-Related Conditions

COMPOSITIONS FOR BACTERIAL MEDIATED GENE SILENCING AND METHODS OF USING SAME

Target point, preparation and method for treating human ADSL deficiency

Double-stranded and single-stranded RNA molecules with 5′ triphosphates and their use for inducing interferon

RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)

RNAi targeting CNTD2

RNAi targeting ZNF205

Modulation of transthyretin expression

Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents

Methods and compositions for treating solid tumors and enhancing tumor vaccines

Compositions for in vivo expression of therapeutic sequences in the microbiome

Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components

Molecular marker for cancer stem cell

METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS

Effect of PpeGID1c on vegetative growth of fruit trees

Methods and compositions for neuroprotection

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, CLASSIFICATION, AND TREATMENT OF CANCER

Reagents and Methods for Treating Cancer

Polynucleotides and methods for inhibiting cancer cells

In vivo production of small interfering RNAs that mediate gene silencing

COMPOSITIONS AND METHODS OF MODULATING B CELL RESPONSE

Therapeutic targets for cancer progression

KIDNEY DISEASE TARGETS AND USES THEREOF

Methods of Using Interleukin-10 for Treating Diseases and Disorders

TREATMENT OF CARDIAC DISEASES WITH MODULATORS OF THE HIPPO PATHWAY

METHODS FOR CATEGORISING CANCER SUCH AS BREAST CANCER

RNA POLYMERASE II33 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders

Method for selectively inhibiting ACAT1 in the treatment of obesity, metabolic syndrome, and atherosclerosis

Control of Varroa mite infestation

RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases

PROKARYOTIC RNAi-LIKE SYSTEM AND METHODS OF USE

Polycomb-associated non-coding RNAs

Oligonucleotide compounds for targeting huntingtin mRNA

Polycomb-associated non-coding RNAs

Double stranded oligonucleotide compounds comprising positional modifications

Targeted therapeutic nucleosides and their use

Anionic polyplexes for use in the delivery of nucleic acids

Compositions and methods for modulating an immune response

Blockade of CCL18 signaling via CCR6 as a therapeutic option in treating interstitial lung disease

Compositions and Methods for Inhibition of PCSK9 Genes

Gamma-secretase inhibition reduce APOC3 levels and plasma triglycerides

Hybridosomes, compositions comprising the same, processes for their production and uses thereof

SPT5 NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS

MUCOSAL HEALING PROMOTER

Compositions and methods for inhibiting expression of the PCSK9 gene

RNA aptamers against BAFF-R as cell-type specific delivery agents and methods for their use

NUCLEIC ACID CHEMICAL MODIFICATIONS

POST-SYNTHETIC CHEMICAL MODIFICATION OF RNA AT THE 2'-POSITION OF THE RIBOSE RING VIA "CLICK" CHEMISTRY

Compositions and methods for inhibiting gene expression of Hif2alpha

Alternative export pathways for vector expressed RNA interference

Compounds of chemically modified oligonucleotides and methods of use thereof

Oligonucleotides and Methods for Treatment of Cardiomyopathy Using RNA Interference

Oligonucleotides and methods for inhibiting or reducing bacterial biofilms

Agents that modulate RGMb-neogenin-BMP signaling and methods of use thereof

LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENT

Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers

SCREENING FOR TARGET-SPECIFIC AFFINITY BINDERS

miR-211 expression and related pathways in human melanoma

Ketohexokinase (KHK) iRNA compositions and methods of use thereof

Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF

Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

Compositions and Methods to Inhibit EZH2 for the Treatment of Cardiovascular Diseases

Clonal analysis of functional genomic assays and compositions for practicing same

In vitro method for identifying compounds of the Nav 1.9 sodium channel intended for the treatment of an inflammatory skin disease

Wound healing compositions and treatments

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

Imino compounds for amphoteric liposomes and uses thereof

Method of diagnosis, prognostic or treatment of neurodegenerative disease

METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM

Oligonucleotide modulators of the toll-like receptor pathway

Anti-tumor therapy

DOUBLE STRANDED RNA COMPOUNDS TO RHOA AND USE THEREOF

5′ triphosphate oligonucleotide with blunt end and uses thereof

Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS Mutations

5′ triphosphate oligonucleotide with blunt end and uses thereof

NUCLEIC ACID CAPABLE OF INHIBITING EXPRESSION OF BETA-2GPI

Method of Treatment of Vascular Complications

Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes

METHODS

Molecular targets for healing or treating wounds

Modulation of synaptic maintenance

RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis

Targeting WSB1 and pVHL to treat cancer

METHODS AND COMPOSITIONS FOR PANIC DISORDERS

Method for Regulating Cell Proliferation

Cationic lipid

Recurrent gene fusions in prostate cancer

MicroRNAs and uses thereof

COMPOSITION FOR PREVENTING OR TREATING OSTEOPOROSIS, CONTAINING PROGRANULIN INHIBITOR AS ACTIVE INGREDIENT

Use of miR-494 to Modulate TRAIL-induced Apoptosis through BIM Down-regulation

Multilayered nanoparticle and methods of manufacturing and using the same

FULLY STABILIZED ASYMMETRIC SIRNA

METHODS OF IMPROVED PROTEIN PRODUCTION USING MIRNAs AND SIRNAs

Regulation of BARD1 expression by non-coding RNA

NOVEL FUSION GENES AS FACTORS RESPONSIBLE FOR GASTRIC CANCER

Targeted nanocarriers for the administration of immunosuppressive agents

NANO DELIVERY SYSTEMS FOR SIRNA

Lipids and lipid compositions for the delivery of active agents

Treating neurodegenerative disease

Synthesis of transcripts using Syn5 RNA polymerase

Modulators of intracellular chloride concentration for treating down syndrome

METHOD OF INDUCING AN IMMUNE RESPONSE

Reduction of lipase activity in product formulations

Composition for regenerating normal tissue from fibrotic tissue

Manganese ion coated nanoparticles for delivery of compositions into the central nervous system by nasal insufflation

METHOD AND PHARMACEUTICAL COMPOSITION FOR INHIBITING NEURONAL REMODELING

Hippo and dystrophin complex signaling in cardiomyocyte renewal

SYSTEM FOR CO-DELIVERY OF POLYNUCLEOTIDES AND DRUGS INTO PROTEASE-EXPRESSING CELLS

Dual Targeting siRNA Agents

Agents and methods to elicit anti-tumor immune response

METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION

Polypeptides, nucleic acids and uses thereof

Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subject

Recombinant virus products and methods for inhibition of expression of myotilin

Liposomal particles, methods of making same and uses thereof

SiRNA and their use in methods and compositions for inhibiting the expression of the ORAI1 gene